Exhibit 107
Calculation of Filing Fee Tables
Form S-3
TNF Pharmaceuticals, Inc.
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered (1) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial effective date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||||||||||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||||||||||||||||||||
Fees to Be Paid | Equity | Common Stock, par value $0.001 per share | Rule 457(c) | 69,143,811 | (2) | $ | 1.845 | (3) | $ | 127,570,331.30 | $ | 0.00014760 | $ | 18,829.38 | ||||||||||||||||||||||||||||
Fees Previously Paid | Equity | Common Stock, par value $0.001 per share | Rule 457(c) | 473,841 | (2) | 2.145 | (4) | $ | 1,016,388.95 | 0.00014760 | $ | 150.02 | ||||||||||||||||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||||||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||||||||||||||||||||
Total Offering Amounts | $ | 128,586,720.25 | ||||||||||||||||||||||||||||||||||||||||
Total Fees Previously Paid | $ | 150.02 | ||||||||||||||||||||||||||||||||||||||||
Total Fee Offsets | ||||||||||||||||||||||||||||||||||||||||||
Net Fee Due | $ | 18,829.38 |
(1) | Pursuant to Rule 416 under the Securities Act of 1933 (the “Securities Act”), the shares being registered hereunder include such indeterminate number of shares of common stock as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions. | |
(2) | Represents an aggregate of 69,617,652 shares of common stock, par value $0.001 per share (the “Common Stock”), (i) issuable upon the conversion of shares of Series F-1 convertible preferred stock (the “Series F-1 Preferred Shares”), (ii) issuable upon the payment of dividends in the form of Common Stock, if any, to the holders of the Series F-1 Preferred Shares (“Dividend Shares”), based on the Company’s reasonable good-faith estimate of the number of Dividend Shares to be issued, if any, (iii) issuable upon the conversion of shares of Series G convertible preferred stock (the “Series G Preferred Shares”), (iv) issuable upon the conversion of additional Series G Preferred Shares, if any, issued as dividends upon election by a holder of the Series G Preferred Shares to be paid such dividends in “kind” in the form of additional Series G Preferred Shares (“PIK Shares”), based on the Company’s reasonable good-faith estimate of the number of PIK Shares to be issued, if any, assuming that the Series G Preferred Shares remain outstanding for a period of five (5) years from the initial issuance date, or (v) upon exercise of certain warrants (the “Warrants”). | |
(3) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) under the Securities Act, based on the average of the high and low prices of the Common Stock as reported on The Nasdaq Capital Market on August 6, 2024, which such date is within five business days of the filing of this registration statement, of $1.845 per share. | |
(4) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) under the Securities Act, based on the average of the high and low prices of the common stock as reported on The Nasdaq Capital Market on June 18, 2024, of $2.145 per share. |